HIM
RVPH

HGC Investment Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

HGC Investment Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$3K – 141
2019
Q2 		$3K Sell
10
-3,315
-100% -$675K ﹤0.01% 105
2019
Q1 		$670K Hold
3,325
– – 0.16% 64
2018
Q4 		$656K Buy
+3,325
New +$652K 0.16% 59

Other funds holding RVPH

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

HGC Investment Management's RVPH Position: Q3 2019 in Review

HGC Investment Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2019, closing a stake of 10 shares — an estimated $3K sold.

HGC Investment Management first reported a position in RVPH in Q4 2018 and held it in 3 quarters. The position peaked at $670K in Q1 2019. 21 funds tracked by Wall St. Rank hold RVPH as of Q3 2019.

  • HGC Investment Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2019 after selling out during the quarter.
  • HGC Investment Management sold 10 REVIVA PHARMA HLDGS INC shares in Q3 2019, an estimated $3K.
  • HGC Investment Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 3 quarters.
  • HGC Investment Management's REVIVA PHARMA HLDGS INC position peaked at $670K in Q1 2019.
  • 21 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2019.

Based on HGC Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.